Technology News and Research

RSS

Derma Sciences adds XTRASORB Foam dressing to advanced wound care product portfolio

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announced the launch of its new XTRASORB™ Foam dressing. The dressing is the company's first novel entry in the $300 million foam wound dressing market. First sales are expected during the second quarter of 2010.

4 May 2010

Reprints Desk launches ePrints NRx scientific article collection service

Derycz Scientific, Inc., the content repurposing company, today announced that its subsidiary Reprints Desk, an award-winning provider of information services and content workflow solutions, has launched ePrints NRx, a new scientific article collection service that simplifies the re-use of PDFs by medical marketers, brand managers and sales professionals.

4 May 2010

Glycos Biotechnologies announces international expansion into Malaysia

Glycos Biotechnologies, Inc., an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today announced the company's international expansion into Malaysia.

4 May 2010

Cerner, Fort HealthCare collaborate to create connected health community

Cerner Corporation announced a strategic partnership with Fort HealthCare, an integrated hospital and health system in Fort Atkinson, Wis., to create a connected health community. Fort HealthCare will work with Cerner to improve the quality of care and make care processes more efficient for more than 120,000 residents in the organization's service area through the use of Cerner Millennium® solutions.

4 May 2010

Generic Flomax launch drives Impax Laboratories first-quarter total revenue to $323.3 million

Impax Laboratories, Inc. today reported significant growth in the first quarter of 2010 due to an increase in sales from its Global product sales channel. Total revenue increased $264.4 million to $323.3 million driven by the successful March 2 exclusive launch of generic Flomax® ($176.2 million of revenue and $167.9 million of gross profit) and continued strong sales of generic Adderall XR® for which there were no comparable amounts in the first quarter 2009, as well as increased sales of the Company's fenofibrate products.

4 May 2010

Theragenics reports highest quarterly consolidated revenue of $20.3 million

Theragenics Corporation®, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the first quarter ended March 31, 2010.

4 May 2010

Rigel Pharmaceuticals reports net loss of $22.3M for first-quarter 2010

Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010.

4 May 2010

NMT Medical reports total revenues of $3.0M for first-quarter 2010

NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter ended March 31, 2010.

4 May 2010

Henry Schein's net sales for first-quarter 2010 increase 18.5% to $1.8 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended March 27, 2010.

4 May 2010

Personalized vaccine processed using tumor tissue promising for brain tumor treatment

Each day in the United States, 482 people are diagnosed with a brain tumor. For these 482 people, not many treatments exist. With the current treatments available, only 5% of those diagnosed with a Glioblastoma Multiform will survive more than 5 years. Only two new treatments have been approved by the FDA in the past two decades.

4 May 2010

Pay-for-performance programs could end up widening medical disparities: RAND study

Rewarding primary care physicians for providing better care to patients could end up widening medical disparities experienced by poorer people and those belonging to racial and ethnic minorities, according to a new RAND Corporation study.

4 May 2010

Role of pharmacists on primary care health teams to be discussed during Health Affairs press briefing

Smith will discuss the role of pharmacists on primary care health teams during a Health Affairs press briefing on Tuesday, May 4 at 11:30 a.m. ET. She will be joined by an interprofessional team of colleagues that includes Christine Cassell of the American Board of Internal Medicine, Joanne Pohl of the University of Michigan School of Nursing and Bill Leinweber from the American Academy of Physician Assistants.

4 May 2010

JNM supplement examines advances in cardiovascular molecular imaging

The Journal of Nuclear Medicine -the top-rated medical imaging journal worldwide-has published Multimodality Molecular Imaging of the Cardiovascular System, presenting the state of the art of cardiovascular molecular imaging and discussing opportunities and challenges in advancing cardiovascular molecular imaging to clinical practice.

4 May 2010

FDA grants market clearance for Illumina's BeadXpress system for multiplex genetic analysis

Illumina, Inc. today announced that the U.S. Food and Drug Administration has granted 510(k) market clearance for the company's BeadXpress system for multiplex genetic analysis.

From Illumina, Inc. 4 May 2010

Merci Retriever receives Shonin approval in Japan

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that the Merci Retriever, Merci Microcatheter, and Merci Balloon Guide Catheter have received Shonin approval in Japan.

4 May 2010

Isolated microalgal strain produces significant amounts of DGLA that helps reduce risk for heart attacks

Ben-Gurion University of the Negev (BGU) researchers have isolated a microalgal strain which produces large amounts of a polyunsaturated fatty acid that could reduce blood pressure, chronic inflammation and blood cholesterol level, reducing the risk for heart attacks.

4 May 2010

Study comparing enteroscopy technologies finds SE quicker than DBE for examining small intestine

Spirus Medical, Inc., a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, announced at Digestive Disease Week 2010 that results from the first-ever prospective study comparing enteroscopy technologies show spiral enteroscopy (SE) to be more than three times faster, on average, than double-balloon enteroscopy (DBE) in examining the small intestine.

4 May 2010

Surgeons can now customize artificial knee implants, prevent future revision surgeries

Throughout the years orthopedic surgeons have learned that one size does not fit all when it comes to joint replacements. Because of advancements in technology, surgeons can now customize artificial knee implants and prevent future revision surgeries.

4 May 2010

Wellstar International commences second Beta Test in Long Term Care Facility

Wellstar International Inc. has announced they have started their second Beta Test in a Long Term Care Facility.

4 May 2010

Researchers explore role of ECoG measurement to improve brain mapping technology

Epilepsy and seizures affect nearly 3 million Americans of all ages, with 200,000 new cases of seizures and epilepsy occurring each year. Epilepsy surgery may be performed in patients who have seizures associated with structural brain abnormalities, such as benign brain tumors and cortical dysplasia, malformations of blood vessels, the genetic disorder tuberous sclerosis, and strokes.

4 May 2010

Technology News and Research

Derma Sciences adds XTRASORB Foam dressing to advanced wound care product portfolio

Reprints Desk launches ePrints NRx scientific article collection service

Glycos Biotechnologies announces international expansion into Malaysia

Cerner, Fort HealthCare collaborate to create connected health community

Generic Flomax launch drives Impax Laboratories first-quarter total revenue to $323.3 million

Theragenics reports highest quarterly consolidated revenue of $20.3 million

Rigel Pharmaceuticals reports net loss of $22.3M for first-quarter 2010

NMT Medical reports total revenues of $3.0M for first-quarter 2010

Henry Schein's net sales for first-quarter 2010 increase 18.5% to $1.8 billion

Personalized vaccine processed using tumor tissue promising for brain tumor treatment

Pay-for-performance programs could end up widening medical disparities: RAND study

Role of pharmacists on primary care health teams to be discussed during Health Affairs press briefing

JNM supplement examines advances in cardiovascular molecular imaging

FDA grants market clearance for Illumina's BeadXpress system for multiplex genetic analysis

Merci Retriever receives Shonin approval in Japan

Isolated microalgal strain produces significant amounts of DGLA that helps reduce risk for heart attacks

Study comparing enteroscopy technologies finds SE quicker than DBE for examining small intestine

Surgeons can now customize artificial knee implants, prevent future revision surgeries

Wellstar International commences second Beta Test in Long Term Care Facility

Researchers explore role of ECoG measurement to improve brain mapping technology

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News